The article reports that major pharmaceutical companies have paused or abandoned nearly £2 billion in planned investments in the UK this year. This includes MSD's decision to scrap a £1 billion research center in London and AstraZeneca's halt on a £200 million expansion of its facilities in Cambridge. The moves have been attributed to the government's plans for the life science sector, a key part of the UK economy, being thrown into disarray. The article suggests these decisions may lead to job losses and could negatively impact patient care. The article also notes that these developments come as the UK government prepares to discuss drug pricing with US President Donald Trump.
Sep 16, 2025 → Sep 16, 2025
The article discusses the potential impact of Donald Trump's threats on the UK's pharmaceutical industry and the National Health Service (NHS). It highlights how Trump's proposal to impose a 250% tariff on medicines made abroad by…
Read original at The Guardian →2 updates from 1 source.
The article discusses the potential impact of Donald Trump's threats on the UK's pharmaceutical industry and the National Health Service (NHS). It highlights how Trump's proposal to impose a 250% tariff on medicines…
Read original at The Guardian →The article reports that major pharmaceutical companies have paused or abandoned nearly £2 billion in planned investments in the UK this year. This includes MSD's decision to scrap a £1 billion research center in London…
Read original at The Guardian →What this story stands on. Tier 0 is a primary record or the subject's own words; higher tiers must be attributed, never stated as bare fact.
The article discusses the potential impact of Donald Trump's threats on the UK's pharmaceutical industry and the National Health Service (NHS). It highlights how Trump's proposal to impose a 250% tariff on medicines made abroad by…
View source →The article reports that major pharmaceutical companies have paused or abandoned nearly £2 billion in planned investments in the UK this year. This includes MSD's decision to scrap a £1 billion research center in London and AstraZeneca's…
View source →Tier key: T0 = Primary source · T1 = Wire · T2 = Outlet report · T3 = Commentary
Long-running fight over Trump-backed maps takes another turn as absentee voting is already under way in Missouri. This blog is now closed. Sign up for US Breaking News emails Xi…
This new task force is Trump's latest response to the debate over AI safety.
The Trump administration’s decision to revoke the visa of a Peruvian judge who sided with a Chinese company in a port dispute puts a new spotlight on the growing US-China rivalry…
As Bosnians vote in an election this weekend, the country is embracing the US president’s family and friends.
On Equity, we discussed the Trump administration's attempts to rebrand AI.
Donald Trump and Xi Jinping discuss Taiwan arms sales every time they get together but the American stance on the self-ruled island remains unchanged following the Chinese…
